相关实验视频

Updated: Sep 8, 2025

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

针对IL-6信号:老年风湿性关节炎患者的安全性和有效性

Hideto Kameda¹, Reina Maezawa², Yasuto Minegishi²

¹Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Ohashi Medical Center), Tokyo, Japan. hideto.kameda@med.toho-u.ac.jp.

|September 5, 2025

概括

在老年类风湿性关节炎患者中,IL-6R抑制剂是安全有效的. 这些疗法具有良好的耐受性,并且不会增加老年人感染,心血管事件或恶性瘤的风险.

科学领域:

免疫学和风湿学
药物监督和药物安全
老年医学

背景情况:

干白素-6 (IL-6) 是免疫媒介性炎症疾病 (IMIDs) 中的主要炎症调解剂.
IL-6受体 (IL-6R) 抑制剂是对类风湿性关节炎 (RA) 的有效治疗方法.
年龄是不良反应的风险因素,需要对老年RA患者的IL- 6R抑制剂进行安全评估.

研究的目的:

评估IL-6R抑制剂的安全性和有效性.
分析沙利卢马布 (SAR) 和托西卢马布 (TCZ) 在老年 RA 群体中的营销后监测 (PMS) 和注册数据.

主要方法:

在日本的RA患者中分析了sarilumab的营销后监测数据.
对日本的PMS数据和法国和德国的注册数据进行审查.
在不同年龄组对安全性和有效性的比较评估.

主要成果:

在老年RA患者中,抗IL- 6R疗法表现出良好的耐受性.
在该群体中,没有观察到IL-6R抑制剂增加心血管事件或恶性瘤的风险.
在老年患者中,托西利祖马布的有效性略有降低,而沙利祖马布在不同年龄组中保持了相似的有效性.

结论:

对于老年患者来说,IL- 6R抑制剂通常是安全有效的.
这些疗法适用于越来越多的IMID老年人.
预计抗IL-6R抗体的使用将扩展到全球其他IMID,特别是在老龄化社会中.

更多相关视频

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...